CDK1-Cyclin B mediated phosphorylation of PP2A-B56 on B56Par1.T73T75 controls mitotic entry timing and Schizosaccharomyces pombe cell size

https://royalsocietypublishing.org/rsob/article/16/8/260089/482862/CDK1-Cyclin-B-mediated-phosphorylation-of-PP2A-B56 19th August 2026

Paper information and key findings

Mitosis is triggered when the rising activity of CDK1-Cyclin B, amplified by the CDK1/Cdc25/Wee1 feedback loop, overcomes inhibitory signalling from Wee1 and counteracting phosphatases. CDK-opposing phosphatases PP1, PP2A-B55 and PP2A-B56 are regulators of mitosis. A screen for differentially phosphorylated sites in a ΔPP1dis2 genetic background in Schizosaccharomyces pombe identified phosphorylation of T73 or T75 in the regulatory B56Par1 subunit. The B56Par1.T73T75 phosphorylation is directly mediated by CDK1-Cyclin B, and a phospho-mimetic mutation increased while a non-phosphorylatable mutation reduced PP2A-B56Par1 phosphatase activity. Blocking B56Par1.T73T75 phosphorylation reduced cell length in unperturbed divisions from 14 to 12 µm, without causing pleiotropic defects. Therefore, blocking phosphorylation at T73T75 alone prematurely unlocked amplification of the CDK1/Cdc25/Wee1 feedback loop, advancing cells into mitosis. Signalling from T73T75 reveals for the first time that timely mitotic commitment in unperturbed cycles is mediated by PP2A-B56.

Groups

Group leader

Research topics & keywords

Filter by group
Filter by group leader
Filter by research topic
Filter by year
Search publications

https://royalsocietypublishing.org/rsob/article/16/8/260089/482862/CDK1-Cyclin-B-mediated-phosphorylation-of-PP2A-B56

CDK1-Cyclin B mediated phosphorylation of PP2A-B56 on B56Par1.T73T75 controls mitotic entry timing and Schizosaccharomyces pombe cell size

19 August 2026

Institute Authors (3)

Lenka Halova, Duncan Smith, Iain Hagan

Labs & Facilities

Biological Mass Spectrometry

array(1) { [0]=> int(3758) }

Research Group

Cell Division

array(1) { [0]=> int(1855) }

https://www.cell.com/immunity/fulltext/S1074-7613(26)00278-5

CCR7+ activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity

4 August 2026

Institute Authors (10)

Erin Richardson, Shih-Chieh Chiang, Massimo Russo, Charles Earnshaw, Anna Pidoux, Poppy Dunn, Sudhakar Sahoo, Antonia Banyard, Natalia Moncaut, Santiago Zelenay

Labs & Facilities

BRU Experimental Team, Computational Biology Support, Genome Editing and Mouse Models, Mass and Flow Cytometry, Transgenic Breeding Team

array(5) { [0]=> int(3679) [1]=> int(3839) [2]=> int(2947) [3]=> int(2104) [4]=> int(9553) }

Research Group

Cancer Inflammation and Immunity

array(1) { [0]=> int(1957) }

https://www.cell.com/cell/fulltext/S0092-8674(26)00522-2

Plasma signals of lung tumor promotion for molecular cancer prevention

25 June 2026

Institute Authors (1)

William Hill

Research Group

Cancer Origins

array(1) { [0]=> int(7954) }

https://link.springer.com/article/10.1038/s44319-026-00809-1

PKMYT1 has an important role in the timing and fidelity of chromosome segregation

5 June 2026

Institute Authors (6)

Asma Belbelazi, Charlie Greenaway-Wells, Zoe Edwards, Wendy Trotter, Keren Dawson, Iain Hagan

Research Group

Cell Division

array(1) { [0]=> int(1855) }

https://www.nature.com/articles/s42255-026-01514-y

Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

27 April 2026

Institute Authors (4)

Amaya Virós, Noah Palombo, Charlotte Russell, Claus Jørgensen

Research Group

Skin Cancer & Ageing

array(1) { [0]=> int(2344) }

https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00114-5

Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity

13 April 2026

Institute Authors (1)

Samra Turajlić

Research Group

Cancer Dynamics

array(1) { [0]=> int(8377) }